Oncolix Inc. (fka ONCX)

[reaper247]

LOL, laraz…that is nonsense.

Just the fact that entire arguments have been reduced to false statements followed by question marks show that nobody is actually willing to make false statements about ONCX and stand by them anymore.

It should now be obvious to anyone who has been following along.

Oncolix has verified in their filings that they initially dosed 3 women in their initial phase one human clinical trials.

Phase 1 a bust?

Nope, the dosing of the second group in phase clinical trials has been initiated and is currently ongoing.

BioVectra is the manufacturer of Prolanta.

BioVectra is a subsidiary of Mallinckrodt Pharmaceuticals NYSE: MNK and the former President of BioVectra is Dale Zajicek, serves on the Oncolix Board of Directors.

Now calculate how many shares were sold to Toxic Financers in the last 778 days times the ratio of PPS decline?

I have already done that for you.

The notes started converting in late 2018 at a time when the ONCX PPS was seeing lows of around .035 to .04. The current PPS is .033.

The relatively small dilution has had very little impact on the PPS.

To claim that ONCX saw a PPS decline from roughly .20 in July 2017 because of CDs that didn’t start converting until late 2017 is a dumb argument to have.

It should be obvious to everyone.

IMO and FWIW.